Simulect 20 mg Film-coated tablets
PDF Leaflet Revision Date: 02 May 2019
Clinical Summary
Quick overview from the medicine insert
Indication
Prophylaxis of organ rejection in de novo renal transplantation.
Dosage (summary)
20 mg IV on days 0 and 4 post-transplant.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Use with caution; limited data on safety in pregnancy and lactation.
Key Drug Interactions
- Ciclosporin
- Corticosteroids
Contraindications
- Hypersensitivity to basiliximab or any component
Common side effects
- Nausea
- Diarrhoea
- Hypertension
- Headache
Counselling Points
- Monitor for signs of infection
- Report any allergic reactions immediately
Serious warnings
- Risk of hypersensitivity reactions
- Increased risk of infections
Important Disclaimer
The Simulect 20 mg Film-coated tablets professional information leaflet below is the property of Novartis South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
